The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'

Launched by ADDPHARMA INC. · Mar 24, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new medication called 'AD-115A' or 'AD-1151' to see how safe it is and how the body processes it after a single dose. The trial is focused on healthy adults and aims to gather important information that could help in treating conditions like gastric ulcers. Participants will receive either of the two medications and will be monitored for their safety and how the medication works in their bodies.

To be eligible for the trial, you need to be at least 19 years old and have a body mass index (BMI) between 18.0 and 30.0, which is a measure of body weight in relation to height. The study is not recruiting participants yet, but if you join, you'll need to avoid certain medications before the trial starts. This is important to ensure accurate results. Participants can expect regular check-ins and monitoring throughout the study to ensure their well-being.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The Age equal to or greater than 19 in healthy volunteers at the time of screening visit
• • Body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening visit
• Exclusion Criteria:
• • Individuals who have taken drugs that induce (e.g., barbiturates) or inhibit drug-metabolizing enzymes within 30 days prior to the start of the study (first dosing day), or have taken drugs that may affect this study within 10 days prior to the start of the study (first dosing day)
• • Other exclusions applied